These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 7933609

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy.
    Hoshi K, Mizushima Y, Kiyokawa S, Yanagawa A.
    Drugs Exp Clin Res; 1986; 12(8):681-5. PubMed ID: 3757764
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical trials of PGE1, PGI2 and mimetics in patients with peripheral vascular disease.
    Sinzinger H, Virgolini I, O'Grady J.
    Prog Clin Biol Res; 1989; 301():85-96. PubMed ID: 2477859
    [No Abstract] [Full Text] [Related]

  • 6. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
    Akahori H, Takamura T, Hayakawa T, Ando H, Yamashita H, Kobayashi K.
    Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Review: recent advances in lipid microsphere technology for targeting prostaglandin delivery.
    Mizushima Y, Hoshi K.
    J Drug Target; 1993 Jun; 1(2):93-100. PubMed ID: 8069557
    [Abstract] [Full Text] [Related]

  • 11. Treatment of established collagen induced arthritis with prostaglandin E1 incorporated in lipid microspheres.
    Moriuchi-Murakami E, Yamada H, Ishii O, Kikukawa T, Igarashi R.
    J Rheumatol; 2000 Oct; 27(10):2389-96. PubMed ID: 11036835
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease.
    Pardy BJ, Lewis JD, Eastcott HH.
    Surgery; 1980 Dec; 88(6):826-32. PubMed ID: 7003784
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of refractory ischemic skin ulcers in patients with Raynaud's phenomenon with PGE1 infusions.
    Langevitz P, Buskila D, Lee P, Urowitz MB.
    J Rheumatol; 1989 Nov; 16(11):1433-5. PubMed ID: 2600942
    [Abstract] [Full Text] [Related]

  • 19. [Clinical effects of lipo-prostaglandin E1 in patients with delayed cerebral vasospasm].
    Korosue K, Izawa I, Hamano S, Ishida K, Kurihara E, Nagao T, Tamaki N, Matsumoto S.
    No Shinkei Geka; 1987 Jun; 15(6):635-40. PubMed ID: 3670536
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.